Francisco Herrera-Gómez

Scopus Author ID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 22

Top Venues

Pharmaceuticals (Basel, Switzerland)

Pharmaceutics

Journal of clinical medicine

Biomedicines

Universidad de Valladolid

Universidad de Valladolid (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad de Valladolid Sep 1o 2015

Spain

Researcher :: Department of Cell Biology, Histology and Pharmacoogy

Education History

Universidad de Valladolid Nov 14o 2013

Spain

PHD

Publications

Eduardo Gutierrez-Abejón, Paloma Criado-Espegel, M Aránzazu Pedrosa-Naudín, Diego Fernández-Lázaro, Francisco Herrera-Gómez, Francisco Javier Álvarez
Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Eduardo Gutierrez-Abejón, Paloma Criado-Espegel, M Aránzazu Pedrosa-Naudín, Diego Fernández-Lázaro, Francisco Herrera-Gómez, Francisco Javier Álvarez
Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Eduardo Gutierrez-Abejón, Paloma Criado-Espegel, M Aránzazu Pedrosa-Naudín, Diego Fernández-Lázaro, Francisco Herrera-Gómez, Francisco Javier Álvarez
Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Eduardo Gutierrez-Abejón, Paloma Criado-Espegel, M Aránzazu Pedrosa-Naudín, Diego Fernández-Lázaro, Francisco Herrera-Gómez, Francisco Javier Álvarez
Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Eduardo Gutierrez-Abejón, Francisco Herrera-Gómez, M Aránzazu Pedrosa-Naudín, Eduardo Tamayo, Francisco Javier Álvarez
Hospitalized COVID-19 Patients with Severe Acute Respiratory Syndrome: A Population-Based Registry Analysis to Assess Clinical Findings, Pharmacological Treatment and Survival. Medicina (Kaunas, Lithuania) 58 (6) (2022)
M Aránzazu Pedrosa-Naudín, Eduardo Gutierrez-Abejón, Francisco Herrera-Gómez, Diego Fernández-Lázaro, Francisco Javier Álvarez
Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study. Pharmaceutics 14 (12) (2022)
M Aránzazu Pedrosa-Naudín, Eduardo Gutierrez-Abejón, Francisco Herrera-Gómez, Diego Fernández-Lázaro, Francisco Javier Álvarez
Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study. Pharmaceutics 14 (12) (2022)
M Aránzazu Pedrosa-Naudín, Eduardo Gutierrez-Abejón, Francisco Herrera-Gómez, Diego Fernández-Lázaro, Francisco Javier Álvarez
Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study. Pharmaceutics 14 (12) (2022)
M Aránzazu Pedrosa-Naudín, Eduardo Gutierrez-Abejón, Francisco Herrera-Gómez, Diego Fernández-Lázaro, Francisco Javier Álvarez
Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study. Pharmaceutics 14 (12) (2022)
Eduardo Gutierrez-Abejón, Francisco Herrera-Gómez, Débora Martín-García, Eduardo Tamayo, Francisco Javier Álvarez
A Population-Based Registry Analysis on Hospitalized COVID-19 Patients with Previous Cardiovascular Disease: Clinical Profile, Treatment, and Predictors of Death. Journal of cardiovascular development and disease 8 (12) (2021)
Francisco Herrera-Gómez, Francisco Javier Álvarez
Healthcare Data for Achieving a More Personalized Treatment of Chronic Kidney Disease. Biomedicines 9 (5) (2021)
Francisco Herrera-Gómez, Eduardo Gutierrez-Abejón, Mercedes García-Mingo, Francisco Javier Álvarez
Positivity to Cocaine and/or Benzoylecgonine in Confirmation Analyses for On-Road Tests in Spain. International journal of environmental research and public health 18 (10) (2021)
Eduardo Gutierrez-Abejón, Paloma Criado-Espegel, Francisco Herrera-Gómez, Francisco Javier Álvarez
Population-Based Registry Analysis of Antidiabetics Dispensations: Trend Use in Spain between 2015 and 2018 with Reference to Driving. Pharmaceuticals (Basel, Switzerland) 13 (8) (2020)
Coralina Bernuy-Guevara, Hassib Chehade, Yannick D Muller, Julien Vionnet, François Cachat, Gabriella Guzzo, Carlos Ochoa Sangrador, Francisco Javier Álvarez, Daniel Teta, Débora Martín-García, Marcel Adler, Félix J de Paz, Frank A Lizaraso-Soto, Manuel Pascual, Francisco Herrera-Gómez
The Inhibition of Complement System in Formal and Emerging Indications: Results from Parallel One-Stage Pairwise and Network Meta-Analyses of Clinical Trials and Real-Life Data Studies. Biomedicines 8 (9) (2020)
Eduardo Gutierrez-Abejón, Eduardo Tamayo, Débora Martín-García, Francisco Javier Álvarez, Francisco Herrera-Gómez
Clinical Profile, Treatment and Predictors during the First COVID-19 Wave: A Population-Based Registry Analysis from Castile and Leon Hospitals. International journal of environmental research and public health 17 (24) (2020)
Francisco Herrera-Gómez, Mercedes García-Mingo, Francisco Javier Álvarez
Benzodiazepines in the oral fluid of Spanish drivers. Substance abuse treatment, prevention, and policy 15 (1) (2020)
Marcel Adler, Francisco Herrera-Gómez, Débora Martín-García, Marie Gavid, Francisco Javier Álvarez, Carlos Ochoa Sangrador
The Impact of Iron Supplementation for Treating Anemia in Patients with Chronic Kidney Disease: Results from Pairwise and Network Meta-Analyses of Randomized Controlled Trials. Pharmaceuticals (Basel, Switzerland) 13 (5) (2020)
Francisco Herrera-Gómez, Mercedes García-Mingo, Mónica Colás, Juan Carlos González-Luque, Francisco Javier Álvarez
Drivers who tested positive for cannabis in oral fluid: a longitudinal analysis of administrative data for Spain between 2011 and 2016. BMJ open 9 (8) (2019)
Francisco Herrera-Gómez, Eduardo Gutierrez-Abejón, Ignacio Ayestarán, Paloma Criado-Espegel, Francisco Javier Álvarez
The Trends in Opioid Use in Castile and Leon, Spain: A Population-Based Registry Analysis of Dispensations in 2015 to 2018. Journal of clinical medicine 8 (12) (2019)
Francisco Herrera-Gómez, M Montserrat Chimeno, Débora Martín-García, Frank Lizaraso-Soto, Álvaro Maurtua-Briseño-Meiggs, Jesús Grande-Villoria, Juan Bustamante-Munguira, Eric Alamartine, Miquel Vilardell, Carlos Ochoa Sangrador, Francisco Javier Álvarez
Cholesterol-Lowering Treatment in Chronic Kidney Disease: Multistage Pairwise and Network Meta-Analyses. Scientific reports 9 (1) (2019)
Christian Ortega-Loubon, Francisco Herrera-Gómez, Coralina Bernuy-Guevara, Pablo Jorge-Monjas, Carlos Ochoa Sangrador, Juan Bustamante-Munguira, Eduardo Tamayo, Francisco Javier Álvarez
Near-Infrared Spectroscopy Monitoring in Cardiac and Noncardiac Surgery: Pairwise and Network Meta-Analyses. Journal of clinical medicine 8 (12) (2019)
Francisco Herrera-Gómez, Diana Monge-Donaire, Carlos Ochoa Sangrador, Juan Bustamante-Munguira, Eric Alamartine, Francisco Javier Álvarez
Correction of Hyponatremia May Be a Treatment Stratification Biomarker: A Two-Stage Systematic Review and Meta-Analysis. Journal of clinical medicine 7 (9) (2018)

Francisco Herrera-Gómez.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Francisco Herrera-Gómez